Ingredient

Omeprazole Enteric Coated Granules

Omeprazole delayed-release granules are used to treat peptic ulcers by reducing gastric acid secretion.

See medicines used for Digestion / Gastritis / Heartburn
All medicines
5
Single ingredient
5
Prescription medication
5

MFDS ingredient code M112240

What does it do?

Omeprazole delayed-release granules contain an ingredient of the proton pump inhibitor class that inhibits gastric acid secretion. It lowers gastric acidity and is used to treat gastrointestinal disorders such as peptic ulcers. The enteric coating prevents degradation by gastric acid, allowing absorption in the small intestine.

Omeprazole reduces the secretion of gastric acid by blocking proton pumps in the gastric wall cells. This decrease in gastric acid helps prevent damage to the gastric mucosa and aids in ulcer healing.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Unlike other gastric acid inhibitors, omeprazole directly inhibits the proton pump, providing a strong and persistent effect. With the enteric coating preventing breakdown by gastric acid, absorption occurs at the precise site.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

5 total

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.